Scholar Rock, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Cambridge MA United States (2012)

Organization Overview

First Clinical Trial
2019
NCT03921528
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Scholar Rock, Inc.